Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Business

>> ASTRAZENECA Latest News

OCT 28, 2014 - BBC

A Must Read - Share

Pfizer refuses to rule out tax deal

US drug giant Pfizer refuses to rule out an acquisition that would help it lower its tax bill, after a deal for the UK's AstraZeneca fell through.

Tags: Pfizer refuses to rule out tax deal,  Astrazeneca Latest News

OCT 28, 2014 - Philadelphia Inquirer

A Must Read - Share

Pfizer quarterly revenue declines two percent. Another AstraZeneca offer in the works?

With potential acquisitions hovering in the background, drugmaker Pfizer said Tuesday that its third-quarter revenue declined two percent from the same period a year ago, from $12.643 billion in 2013 to $12.361 billion in 2014.

Tags: Pfizer quarterly revenue declines two percent. Another AstraZeneca offer in the works?,  Astrazeneca Latest News

OCT 28, 2014 - Yahoo! News

A Must Read - Share

Pfizer beats sales and profit forecasts, mum on future deals

(Reuters) - Pfizer Inc reported stronger-than-expected quarterly results, helped by growing sales of its cancer drugs and demand for its medicines in emerging markets, but did not signal any acquisition plans in the wake of its recent failed efforts to buy rival British drugmaker AstraZeneca Plc . The largest U.S. drugmaker on Tuesday said it had earned $2.67 billion, or ...

Tags: Pfizer beats sales and profit forecasts, mum on future deals,  Astrazeneca Latest News

OCT 28, 2014 - Reuters

A Must Read - Share

Pfizer beats third-quarter forecasts, mum on likely future deals

(Reuters) - Pfizer Inc reported better than expected quarterly results, helped by growing sales of its cancer drugs and demand for its medicines in emerging markets, but did not signal any acquisition plans in the wake of its recent failed efforts to buy rival British drugmaker AstraZeneca Plc .

Tags: Pfizer beats third-quarter forecasts, mum on likely future deals,  Astrazeneca Latest News

OCT 24, 2014 - TheStreet

A Must Read - Share

Pfizer (PFE) $11B Stock Repurchase Plan May End AstraZeneca (AZN) Bid

NEW YORK (TheStreet) -- Shares of Pfizer Inc are climbing, up 1.68% to $29.08 in midday trading, after theaU.S. drug maker announced late yesterday that it willacontinue buying back stock, deflating expectations that it will make a new bid to buy British rivalaAstraZeneca , Reuters reports. Earlier this year, Pfizer failed in its $118 billion bid to buy AstraZeneca but ...

Tags: Pfizer (PFE) $11B Stock Repurchase Plan May End AstraZeneca (AZN) Bid,  Astrazeneca Latest News